Automated Insulin Delivery Reduces Overnight Diabetes Management by Caregivers While Improving Nocturnal Glycemic Control in Young Children With Type 1 Diabetes - Scorecard - MDSpire
Clinical Scorecard: Automated Insulin Delivery Enhances Overnight Glycemic Control in Young Children With Type 1 Diabetes While Alleviating Caregiver Burden
At a Glance
Category
Detail
Condition
Type 1 Diabetes in Young Children
Key Mechanisms
Automated insulin delivery system regulates basal insulin delivery and administers correction boluses based on sensor glucose measurements.
Target Population
Children aged 2–6 years with type 1 diabetes.
Care Setting
Clinical trial setting with automated insulin delivery systems.
Key Highlights
Total daily insulin dose increased from 13.3 to 16.2 IU/day (p < 0.001).
Automated insulin delivery significantly increased time in range (TIR) from 60.6% to 78.3% overnight (p < 0.001).
User-initiated correction boluses decreased during the dusk interval (20:00–24:00).
Automated insulin delivery reduced glucose variability from 00:00 to 05:00.
48% of participants used the temporary target feature during the study.
Guideline-Based Recommendations
Diagnosis
Monitor glucose levels regularly using continuous glucose monitoring.
Management
Utilize automated insulin delivery systems for improved glycemic control.
Monitoring & Follow-up
Assess insulin delivery patterns and glucose profiles hourly.
Risks
Potential for hypoglycemia if insulin delivery is not properly adjusted.
Patient & Prescribing Data
Children aged 2–6 years with type 1 diabetes.
Increased total daily insulin dose and stable glucose levels observed with automated insulin delivery.
Clinical Best Practices
Implement automated insulin delivery systems to enhance overnight glycemic control.
Educate caregivers on the use of temporary target settings during periods of low insulin requirements.
